Delving into the Latest Updates on Interleukin-6(Ajinomoto Co., Inc.) with Synapse

Overview

Basic Info

Drug Type

Interleukins

Synonyms-

Target

IL-6RA

Action

agonists

Mechanism

IL-6R agonists(Interleukin-6 receptor alpha subunit agonists)

Therapeutic Areas

Hemic and Lymphatic Diseases

Active Indication-

Inactive Indication

Thrombocytopenia

Originator Organization

Ajinomoto Co., Inc.

Active Organization-

Inactive Organization

Ajinomoto Co., Inc.

Drug Highest PhaseDiscontinuedPhase 2

First Approval Date-

Regulation-

Login to view timeline

Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to conventional synthetic disease-modifying antirheumatic drugs: Comparative study with Filgotinib and interleukin 6 inhibitor examined by clinical index as well as musculoskeletal ultrasound assessment(TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

Start Date25 May 2021

Sponsor / Collaborator-

100 Clinical Results associated with Interleukin-6(Ajinomoto Co., Inc.)

Login to view more data

100 Translational Medicine associated with Interleukin-6(Ajinomoto Co., Inc.)

Login to view more data

100 Patents (Medical) associated with Interleukin-6(Ajinomoto Co., Inc.)

Login to view more data

10

Literatures (Medical) associated with Interleukin-6(Ajinomoto Co., Inc.)

01 Dec 1980·No to shinkei = Brain and nerve

[Habituation of orbicularis oculi reflex and brain monoamines (author's transl)].

Article

Author: Yamashiro, K

01 Nov 1978·British Journal of Pharmacology

Response of the cardiovascular system to lower body negative pressure (LBNP) in rabbits treated with 6-hydroxydopamine [proceedings].

Article

Author: Tomlinson, D R ; Chance, E

01 Jun 1977·International archives of occupational and environmental health

Article

Author: A. Beutha ; H. Krekeler ; G. von Nieding

100 Deals associated with Interleukin-6(Ajinomoto Co., Inc.)

Login to view more data

External Link

KEGG	Wiki	ATC	Drug Bank
-	Interleukin-6(Ajinomoto Co., Inc.)	-	-

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Thrombocytopenia	Phase 2	-	Ajinomoto Co., Inc.	-

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data